A number of HESI committees will be attending the Safety Pharmacology Society (SPS) Annual Meeting
Don’t miss the Symposium on September 12th, Class I Antiarrhythmics and Cardiac Conduction Abnormalities- Beyond hERG and QT Prolongation, featuring concepts from the HESI Cardiac ProA Working Group.
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-8403
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.